NEW YORK, June 5, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of UroGen Pharma Ltd. (NASDAQ: URGN) between July 27, 2023 and May 15, 2025, both dates inclusive (the "Class...
Hence then, the article about urgn investors have opportunity to lead urogen pharma ltd securities fraud lawsuit was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( URGN Investors Have Opportunity to Lead UroGen Pharma Ltd. Securities Fraud Lawsuit )
Also on site :
- Astros Option Mike Burrows
- 6,000-year-old broken ribs discovered in Syria may be one of the oldest known cases of child abuse in the world
- This Massive Hisense U7 QLED TV Is 43% Off, Its Lowest Price Ever